Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1995-05-19
1996-08-20
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424428, 424 7804, 514561, 514772, 514912, 514647, 514944, A61K 31195
Patent
active
055476805
ABSTRACT:
A topical gel formulation containing aminocaproic acid prevents secondary hemorrhage following hyphema without the adverse side effects associated with systemically delivered aminocaproic acid. Of ten human patients treated with the formulation, none have experienced a secondary hemorrhage and none have experienced adverse side effects. The topical gel formulation is prepared by a process which ensures sterility, a pH compatible with conditions in the aqueous humor, and optimum consistency. A permeation enhancer such as proparacaine can be incorporated into the gel during formulation and be used to enhance the transport of aminocaproic acid across the corneal epithelium.
REFERENCES:
patent: 4804539 (1989-02-01), Guo
A Uingham et al Archives of Ophthalmology 105, 1987, p. 1421.
A Uingham et al Archives of Ophthalmology 106, 1988 p. 1436.
Ehlers et al Invest--Ophthalmology Vis Science 31, 1990 p. 2389.
Crouch, Jr. Earl R.
Williams Patricia B.
Eastern Virginia Medical School
Kishore Gollamudi S.
The Center for Innovative Technology
LandOfFree
Method for preparing a topical, aminocaproic acid containing oph does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preparing a topical, aminocaproic acid containing oph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preparing a topical, aminocaproic acid containing oph will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2328683